Cynvenio Liquid Biopsy Automated Rare Cell Isolati As-is, CLEARANCE!
Cynvenio Liquid Biopsy Automated Rare Cell Isolati As-is, CLEARANCE!
Cynvenio Liquid Biopsy Automated Rare Cell Isolati As-is, CLEARANCE!
Cynvenio Liquid Biopsy Automated Rare Cell Isolati As-is, CLEARANCE!
Cynvenio Liquid Biopsy Automated Rare Cell Isolati As-is, CLEARANCE!
Cynvenio Liquid Biopsy Automated Rare Cell Isolati As-is, CLEARANCE!
Cynvenio Liquid Biopsy Automated Rare Cell Isolati As-is, CLEARANCE!
Cynvenio Liquid Biopsy Automated Rare Cell Isolati As-is, CLEARANCE!

Cynvenio Liquid Biopsy Automated Rare Cell Isolati As-is, CLEARANCE!

sku: 7775763
1 In Stock
Condition : Pre-owned
Warranty : AS-IS
Region : EU
€4,999.00€10,000.00
Apply For Finance
Make Offer
Enquiry Here
ADD TO CART
  • Make Cynvenio
  • Hertz 50Hz/60Hz
  • Model LiquidBiopsy Platform v1.2
  • Serial CB 038-141130
  • Weight 148
  • Voltage 120V/220V
  • Working Working
  • Includes Power Cord
  • Warranty AS-IS
  • Dimensions 76×100×114 in
  • Shipping Type Freight
  • Item Condition Pre-owned

If applicable: Unit Powers on, no visible error messages or error codes.

Cynvenio Liquid Biopsy Automated Rare Cell Isolation Ver 1.2

 

 

  The LiquidBiopsy Platform simplifies the isolation, enumeration, and molecular analysis of rare cells and cell-free DNA (cfDNA) from whole-blood samples. Achieving high target cell recovery and exceptional purity, the platform enables downstream molecular characterization of rare cells using next-generation sequencing (NGS), FISH and IHC.

 

  The LiquidBiopsy Platform is part of a comprehensive, cost-effective workflow for the automated isolation, enumeration, and analysis of rare cells. High CTC capture rates are critical in patient monitoring applications because thereare usually less than 10 CTCs in a 7.5 mL whole blood sample (1 target cell per billion).

 

  Sample multiplexing and a one-day blood drawto-sequence workflow accelerate turnaround time for higher- throughput laboratories.

 

  The proprietary Cynvenio sheath flow chip uniquely supports patient monitoring applications. It achieves high purity while capturing CTCs using immunomagnetic positive selection. This flow chip enables low-input DNA sequencing without the need for whole-genome amplification. The chip can then be used to stain and scan the captured target cells.

 

 

Manufacture Specifications

  • Optimized LiquidBiopsy worflow

 

  • Up to a 48 hour turn-around

 

  • Variant detection: 0.1% to 1% sensitivity

 

  • CTC enrichment: 1 in a billion cells

 

  • Detects somatic & germline mutations

 

The flexible design of the LiquidBiopsy platform supports a variety of research areas, including:

  • Oncology

 

  • Endothelial Cells

 

  • Stem Cell Research

 

  • Fetal Cells / Noninvasive Prenatal Testing (NiPT)

 

  • Immunology

 

  • Peptide/Aptamer Libraries

 

  • Infectious Disease

 

 

Testimonials

★★★★★

“REUZEit has been a great partner for our used equipment needs and always provide timely updates of new arrivals of consigned equipment.”

★★★★★

“Great company to work with. Tammy completed our first international equipment shipment with ease.”

★★★★★

“Fast response, open to adjusting schedule as needed, and great customer interaction.”